About
Capsigen engineers customized adeno-associated virus (AAV) capsids using its proprietary Transcription-Dependent Directed Evolution (TRADE™) platform to create targeted and efficient gene therapy delivery vectors for various diseases.
Explore Capsigen's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.